Health Care & Life Sciences » Pharmaceuticals | Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. | Mutual Funds

Mutual Funds that own Teva Pharmaceutical Industries Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
American Funds EuroPacific Growth Fund
50,564,958
4.97%
362,799
0.81%
06/30/2018
American Funds Growth Fund of America
36,935,533
3.63%
0
0.46%
06/30/2018
American Funds Investment Company of America
22,442,300
2.2%
0
0.56%
06/30/2018
Harbor International Fund
21,030,064
2.06%
260,767
2.13%
06/30/2018
Vanguard Health Care Fund
19,274,601
1.89%
-8,709,100
0.88%
06/30/2018
Templeton Growth Fund
14,026,252
1.38%
3,815,815
2.29%
12/31/2017
American Funds Capital World Growth & Income Fund
13,907,575
1.37%
787,000
0.36%
06/30/2018
American Funds Insurance Series - Blue Chip Inc. & Growth Fd.
10,833,800
1.06%
0
2.82%
06/30/2018
FTIF SICAV - Templeton Growth (Euro) Fund
8,413,070
0.83%
-497,700
2.19%
06/30/2018
Templeton Foreign Fund
7,864,800
0.77%
0
2.67%
03/31/2018

About Teva Pharmaceutical Industries

View Profile
Address
5 Basel Street
Petach Tikva HM 49131
Israel
Employees -
Website http://www.tevapharm.com
Updated 07/08/2019
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams.